P, L., & BM, B. (2022). Adalimumab-associated Acquired Hemophilia in a Patient with Scleritis. Ocular immunology and inflammation, 30(2), 294. https://doi.org/10.1080/09273948.2020.1808227
Chicago Style (17th ed.) CitationP, Liberman, and Burkholder BM. "Adalimumab-associated Acquired Hemophilia in a Patient with Scleritis." Ocular Immunology and Inflammation 30, no. 2 (2022): 294. https://doi.org/10.1080/09273948.2020.1808227.
MLA (9th ed.) CitationP, Liberman, and Burkholder BM. "Adalimumab-associated Acquired Hemophilia in a Patient with Scleritis." Ocular Immunology and Inflammation, vol. 30, no. 2, 2022, p. 294, https://doi.org/10.1080/09273948.2020.1808227.
Warning: These citations may not always be 100% accurate.